Truvada was also the overall highest-selling drug on the market for the treatment of HIV in 2006, with sales of approximately US$1.2 billion worldwide 1. The first cross-class combination NRTI ...

Drug firm Lupin on Friday said it has received approval from the US health regulator to market a generic HIV medication in ...

Real-world analyses have confirmed the efficacy of the 2-drug regimen of dolutegravir and lamivudine in treating HIV, ...

This new generic medicine is designed to be a simple, once-daily treatment for children as young as three months old who ...

Lenacapavir works by targeting the HIV capsid, a protein shell that protects the virus’s genetic material. The drug is not a standalone therapy and must be used in combination with other ...

The fixed-dose combination of Abacavir 60 mg/Dolutegravir 5 mg/Lamivudine 30 mg tablets for oral suspension is a once-daily ...

a trial was published comparing the drug lenacapavir, injected once every six months, with a daily oral combination pill to prevent HIV infection in women in Africa. The trial was a tremendous ...

Lenacapavir works by targeting the HIV capsid, a protein shell that protects the virus's genetic material. The drug is not a standalone therapy and must be used in combination with other ...

Every week, 4000 young women contract HIV. Discover hidden barriers to prevention and innovative solutions that can change ...